Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esmolol for cardiac recovery after valve replacement surgery
PACTR201801003026226Completed
- Sponsor
- Faculty of Medicine, Menoufia University
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esmolol in rheumatic heart disease (RHD) (2 arms), sponsored by Faculty of Medicine, Menoufia University. Primary endpoint: Recovery time. Started Jan 2017; status: completed.
02
Drugs
esmolol
03
Conditions
rheumatic heart disease (RHD)
Beyond the preview
Go deeper on PACTR201801003026226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201801003026226.